MENU
ONVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Organovo Holdings (ONVO) Ownership - Who owns Organovo Holdings?
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
11555 Sorrento Valley road
Phone
+1 858 224-1000
Employees
24
Web
https://www.organovo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.86M
P/E Ratio
N/A
Total Cash
1.16M
Projected Growth
N/A
Total Debt
1.06M
Revenue
122K
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
0.03
Revenue/Share
0.01 USD as % of share price
Fundamentals
ONVO
Capitalization
7.87M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
1.16M
Total Cash/Share
0.07
Total Debt
1.06M
Total Debt/Equity
0.03
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
122K
ROE
N/A
Book Value
364K
P/B Ratio
21.60
Cash Flow
N/A
Earnings
-0.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
0.72
Current Revenue Per Employee
1714.29
Dividends Per Share - Security
N/A
EBITDA
-12.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.67
Revenue To Assets
-194.66
Shares Held By Institutions
1.35M
Shares Outstanding - Current
17.5M
Total Liabilities
3.48M
Total Volume MTD
N/A
Value
-1
Gain YTD
31.985
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in developing and commercializing functional human tissues
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
11555 Sorrento Valley road
Phone
+1 858 224-1000
Employees
24
Web
https://www.organovo.com